
The medical research services provider collected funding from investors including Cash Capital, an investment arm of CAS which previously backed a series A.
MIT's The Engine has returned to back membrane-based separation technology spinout Via Separations, after previously investing an undisclosed sum in 2017.
The series A round reportedly featured UCLA Ventures, with the cash going towards expanding the business and technology for FanFood’s events concession app.
The Cambridge spinout plans to build out the business for its automated customer support platform after collecting $12m in series A funding.
Zurich brain injury antibody spinout NovaGo has extended its strategic partnership with immunotherapy company Neurimmune by securing its support in a series A round.
GV and Alexandria have taken part in a $191m round to launch Maze Therapeutics with scientific co-founders from multiple universities such as Harvard and Stanford.
Sanger Institute-founded PetMedix is working on antibodies for dogs and cats based on an immune system discovery model that will adapt and extend earlier human health research.
Alphabet's venturing unit has led a $22m series A extension for MIT spinout Lightmatter, which increased the round's total to $33m.
Zurich immuno-oncology spinout Anaveon raised $35.1m from Novartis Venture Fund and Syncona in addition to seed-stage notes converted by the UZH Life Sciences Fund.
MIT spinout Ginkgo Bioworks has set up Motif Ingredients with $90m in series A funding provided by investors including Louis Dreyfus Company and Fonterra.